REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Servier Indonesia (Indonesia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: PT Servier Indonesia Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

PT Servier Indonesia is engaged in pharmaceuticals trading and importer. The company product are oral anti-diabetics, chronis venous insufficincy & hemmorrhoid disease, anti-asthenia, anti-hypertension & chronis heart failure, diuretic anti-hypertension, anti-angina, anti-depressant, cardio vascular diseases, diabetes, neuro, osteoporosis, venous disease, etc.

Headquarters
Menara Kadin Indonesia Lantai 18 Jl. HR. Rasuna Said Blok X-5 Kav. 2-3
South Jakarta; Jakarta; Postal Code: 12950

Contact Details: Purchase the PT Servier Indonesia report to view the information.

Website: http://www.servier.co.id

Basic Information
Total Employees:
Purchase the PT Servier Indonesia report to view the information.
Outstanding Shares:
Purchase the PT Servier Indonesia report to view the information.
Registered Capital:
Purchase the PT Servier Indonesia report to view the information.
Financial Auditors:
Purchase the PT Servier Indonesia report to view the information.
Incorporation Date:
March 14, 1981
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Servier Indonesia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
0.64%
Total operating revenue
0.64%
Total assets
-2.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?